Contact: Rachel Cagan, email@example.com, 202-375-6395
WASHINGTON (Feb 25, 2019) -
The American College of Cardiology will expand the JACC family of journals with the launch of JACC: CardioOncology in September 2019. Bonnie Ky, MD, MSCE, FACC, will serve as Editor-in-Chief.
JACC: CardioOncology will aim to publish the most impactful original research and state-of-the-art review articles pertaining to this rapidly emerging field. The journal will consist of original articles related to basic, translational, and clinical investigations in cardio-oncology. Topics of interest will include basic and translational mechanisms of cardiotoxicity; early diagnosis, risk stratification, prevention, and treatment of cardiotoxicity; and the multi-disciplinary care of cancer patients and survivors with cardiovascular risk factors and disease.
Ky will begin her five-year term as Editor-in-Chief in March 2019. She is an associate professor of medicine and epidemiology and a physician scientist at the Perelman School of Medicine at the University of Pennsylvania. She leads a highly active National Institutes of Health-funded translational research program in cardio-oncology and is the Principal Investigator of multiple cohort studies and clinical trials focused on the cardiotoxic effects of various cancer therapies. Her programmatic objectives are to understand how to improve cardiovascular outcomes in cancer patients by determining individual patient risk through detailed phenotyping of clinical characteristics, biologic markers and echocardiography-derived measures of myocardial mechanics and function.
Ky is also the founding director of the Penn Cardio-Oncology Center of Excellence, National Cancer Institute-funded ECOG ACRIN Cardiotoxicity Subcommittee Chair, and director of the Penn Center for Quantitative Echocardiography. She is an inducted member of the American Society of Clinical Investigation. She is also a section editor for cardio-oncology for JACC.
“It is a great honor to serve as the inaugural Editor-in-Chief of JACC: CardioOncology,” Ky said. “My vision is for the journal to play a vital and transformative role in advancing the cardiovascular care of a growing cancer population through the dissemination of knowledge and the education of providers who care for cancer patients.”
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its more than 52,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.
The Journal of the American College of Cardiology ranks among the top cardiovascular journals in the world for its scientific impact. JACC is the flagship for a family of journals—JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology and JACC: Basic to Translational Science—that prides themselves in publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.